Literature DB >> 8807798

A kinetic study of NMC-A beta-lactamase, an Ambler class A carbapenemase also hydrolyzing cephamycins.

S Mariotte-Boyer1, M H Nicolas-Chanoine, R Labia.   

Abstract

In order to analyze its kinetic parameters, an Ambler class A carbapenemase NMC-A was purified. NMC-A demonstrated unusually strong hydrolytic activity towards imipenem and meropenem. Moreover, it hydrolyzed cephamycins with kcat values uncommonly high for this class of beta-lactamases. Clavulanic acid and tazobactam had comparable inhibitory activity against NMC-A, whereas sulbactam was the least active inhibitor. Noticeably, NMC-A was more readily inhibited by brobactam. All these catalytic properties suggest that NMC-A possesses an original structure of its active site allowing hydrolysis of beta-lactams usually stable to the hydrolytic activity of class A beta-lactamases.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8807798     DOI: 10.1111/j.1574-6968.1996.tb08457.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  19 in total

1.  Characterization of a Novel Putative Xer-Dependent Integrative Mobile Element Carrying the bla(NMC-A) Carbapenemase Gene, Inserted into the Chromosome of Members of the Enterobacter cloacae Complex.

Authors:  Alberto Antonelli; Marco Maria D'Andrea; Vincenzo Di Pilato; Bruno Viaggi; Francesca Torricelli; Gian Maria Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2015-07-27       Impact factor: 5.191

Review 2.  A Structure-Based Classification of Class A β-Lactamases, a Broadly Diverse Family of Enzymes.

Authors:  Alain Philippon; Patrick Slama; Paul Dény; Roger Labia
Journal:  Clin Microbiol Rev       Date:  2016-01       Impact factor: 26.132

Review 3.  Carbapenemases: the versatile beta-lactamases.

Authors:  Anne Marie Queenan; Karen Bush
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

Review 4.  Catalytic properties of class A beta-lactamases: efficiency and diversity.

Authors:  A Matagne; J Lamotte-Brasseur; J M Frère
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

5.  Identification of products of inhibition of GES-2 beta-lactamase by tazobactam by x-ray crystallography and spectrometry.

Authors:  Hilary Frase; Clyde A Smith; Marta Toth; Matthew M Champion; Shahriar Mobashery; Sergei B Vakulenko
Journal:  J Biol Chem       Date:  2011-02-22       Impact factor: 5.157

6.  Genetic and Biochemical Characterization of FRI-1, a Carbapenem-Hydrolyzing Class A β-Lactamase from Enterobacter cloacae.

Authors:  Laurent Dortet; Laurent Poirel; Samia Abbas; Saoussen Oueslati; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

7.  Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae.

Authors:  H Yigit; A M Queenan; G J Anderson; A Domenech-Sanchez; J W Biddle; C D Steward; S Alberti; K Bush; F C Tenover
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

8.  Importance of position 170 in the inhibition of GES-type β-lactamases by clavulanic acid.

Authors:  Hilary Frase; Marta Toth; Matthew M Champion; Nuno T Antunes; Sergei B Vakulenko
Journal:  Antimicrob Agents Chemother       Date:  2011-01-10       Impact factor: 5.191

9.  P174E Substitution in GES-1 and GES-5 β-Lactamases Improves Catalytic Efficiency toward Carbapenems.

Authors:  Alessandra Piccirilli; Paola Sandra Mercuri; Moreno Galleni; Massimiliano Aschi; André Matagne; Gianfranco Amicosante; Mariagrazia Perilli
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

10.  Biochemical Characterization of SFC-1, a class A carbapenem-hydrolyzing beta-lactamase.

Authors:  Fátima Fonseca; Ana Cristina Sarmento; Isabel Henriques; Bart Samyn; Jozef van Beeumen; Pedro Domingues; Maria Rosário Domingues; Maria José Saavedra; António Correia
Journal:  Antimicrob Agents Chemother       Date:  2007-09-17       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.